| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Lisman Michael | President & CEO | 1350 EUCLID AVENUE, SUITE 1600, CLEVELAND | /s/ Rachel L. Quinlan as attorney in fact for Michael Lisman | 06 Nov 2025 | 0001748275 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TDG | Stock Option | Award | $0 | +75,696 | $0.000000 | 75,696 | 04 Nov 2025 | Common Stock | 75,696 | $1291.97 | Direct | F1 | |
| transaction | TDG | Stock Option | Award | $0 | +3,907 | $0.000000 | 3,907 | 04 Nov 2025 | Common Stock | 3,907 | $1291.97 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | These options are exercisable at 20% per year over five years beginning September 30, 2026 subject to the achievement of annual operating performance targets in each year |
| F2 | These options are exercisable at 80% in 2026 and 20% in 2027 subject to achievement of annual operating performance targets each year. |